Study of Daclizumab in Patients With Chronic, Persistent Asthma
Clinical trial NCT00028288 · COMPLETED
Trial details
- NCT number
- NCT00028288
- Sponsor
- Facet Biotech
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Primary completion
- 2003-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.